Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Topical
Emulsifying Agents
Film Formers & Plasticizers
Surfactant & Foaming Agents
Thickeners and Stabilizers
Direct Compression
Co-Processed Excipients
Rheology Modifiers
Fillers, Diluents & Binders
Coating Systems & Additives
API Stability Enhancers
Controlled & Modified Release
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
37
PharmaCompass offers a list of Tafluprost API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafluprost manufacturer or Tafluprost supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafluprost manufacturer or Tafluprost supplier.
PharmaCompass also assists you with knowing the Tafluprost API Price utilized in the formulation of products. Tafluprost API Price is not always fixed or binding as the Tafluprost Price is obtained through a variety of data sources. The Tafluprost Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zioptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zioptan, including repackagers and relabelers. The FDA regulates Zioptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zioptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zioptan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zioptan supplier is an individual or a company that provides Zioptan active pharmaceutical ingredient (API) or Zioptan finished formulations upon request. The Zioptan suppliers may include Zioptan API manufacturers, exporters, distributors and traders.
click here to find a list of Zioptan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zioptan DMF (Drug Master File) is a document detailing the whole manufacturing process of Zioptan active pharmaceutical ingredient (API) in detail. Different forms of Zioptan DMFs exist exist since differing nations have different regulations, such as Zioptan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zioptan DMF submitted to regulatory agencies in the US is known as a USDMF. Zioptan USDMF includes data on Zioptan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zioptan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zioptan suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Zioptan Drug Master File in Japan (Zioptan JDMF) empowers Zioptan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Zioptan JDMF during the approval evaluation for pharmaceutical products. At the time of Zioptan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Zioptan suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zioptan Drug Master File in Korea (Zioptan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zioptan. The MFDS reviews the Zioptan KDMF as part of the drug registration process and uses the information provided in the Zioptan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zioptan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zioptan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zioptan suppliers with KDMF on PharmaCompass.
A Zioptan written confirmation (Zioptan WC) is an official document issued by a regulatory agency to a Zioptan manufacturer, verifying that the manufacturing facility of a Zioptan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zioptan APIs or Zioptan finished pharmaceutical products to another nation, regulatory agencies frequently require a Zioptan WC (written confirmation) as part of the regulatory process.
click here to find a list of Zioptan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zioptan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zioptan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zioptan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zioptan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zioptan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zioptan suppliers with NDC on PharmaCompass.
Zioptan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zioptan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zioptan GMP manufacturer or Zioptan GMP API supplier for your needs.
A Zioptan CoA (Certificate of Analysis) is a formal document that attests to Zioptan's compliance with Zioptan specifications and serves as a tool for batch-level quality control.
Zioptan CoA mostly includes findings from lab analyses of a specific batch. For each Zioptan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zioptan may be tested according to a variety of international standards, such as European Pharmacopoeia (Zioptan EP), Zioptan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zioptan USP).
